# Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke

Study · id `cardio:ct-nct02643784` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02643784](<https://clinicaltrials.gov/study/NCT02643784>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02643784

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02643784. Randomized; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2017-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02643784, source copy `cardio:ctgov-nct02643784-2015-12-31`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02643784, source copy `cardio:ctgov-nct02643784-2015-12-31`, retrieved 2026-10-26)
- Primary completion: 2017-07 (anticipated) (ClinicalTrials.gov record NCT02643784, source copy `cardio:ctgov-nct02643784-2015-12-31`, retrieved 2026-10-26)
- Completion: 2017-07 (anticipated) (ClinicalTrials.gov record NCT02643784, source copy `cardio:ctgov-nct02643784-2015-12-31`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02643784-2015-12-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
- Acronym: AIS
- Condition: Ischemic
- Intervention (Drug): Rosuvastatin
- Intervention (Other): Control
- Lead sponsor: RenJi Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: RenJi Hospital (`cardio:org-renji-hospital`)

## Provenance

Content hash: fae10550b61f02d93390dffc8119985dbef2174f66efc00fd4125f4b3ec3aa7c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
